Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms-Reference-Cited by-同舟云学术

Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms

Published:2019-08 Issue:8 Volume:4 Page:1085-1093
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Sekulic Miroslav,Waikar Sushrut,Motwani Shveta S.,Weins Astrid,Rennke Helmut G.

Publisher

Elsevier BV

Subject

Nephrology

Reference28 articles.

1. Biochemical testing in neuroendocrine tumors;Aluri;Endocrinol Metab Clin North Am,2017

2. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN):When to consider, how to diagnose?;Fottner;Rev Endocr Metab Disord,2017

3. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones;Nobels;J Clin Endocrinol Metab,1997

4. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure;O'Connor;Clin Chem,1989

5. Recurrent acute kidney injury associated with metastatic bronchial carcinoid;Barton;Am J Med Sci,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Case | A paraneoplastic kidney injury?;Kidney International;2023-08

2. Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy;Kidney International Reports;2023-08

3. Paraneoplastic cast nephropathy associated with malignant prolactinoma: A case report and literature review;Clinical Nephrology;2022-07-01

4. Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy;Kidney International Reports;2021-12